1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Oncology Drug Pathway Analyzer (Standard Version)

EXTRA: Free online updates for a year

Get instant, interactive pathway modeling on more than 3,500 cancer drugs across more than 100 different cancer types.

Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. This highly unique interactive tool is based on BioSeeker’s linking of hundreds of drug targets in many different types of cancer to a wide array of pathways. The included drugs are all from early stage development to market in maturity; also featuring ceased and suspended drugs.

The Oncology Drug Pathway Analyzer is an interactive high level data tool to analyze several thousand drug-pathway connections in more than 100 different cancer indications on the fly. The tool lets you examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.).

The Oncology Drug Pathway Analyzer is a great facilitator to realize your position and options in drug development when utilizing pathways and it significantly cuts the amount of time it takes to do so.

Read more below on how to bring out the power in your pipeline and start to quickly analyze the impact of emerging pathway data in cancer by getting your own version of the Oncology Drug Pathway Analyzer.

Why you should use this tool:
- Map the competition and find suitable benchmarking drugs based on specific pathways and drug properties
- Reveal repositioning opportunities for your older, shelved drugs
- Evaluate the progression and success of targeting certain pathways for the treatment of cancer
- Investigate drugs which affect crosstalk between key pathways
- Investigate different combination therapy options available to you in various cancer types. Use this tool to look for the most-efficient ways to combine your drug with other targeted agents.
- Find possible adjuvant therapy settings with other drugs

Real case scenario (combination therapy):
In the March 20, 2012 issue of the journal Cancer Cell, researchers at The University of Texas MD Anderson Cancer Center reveal that the mTOR molecular pathway stimulates the activity of the Gli1 protein in the development and progression of esophageal cancer. Hitherto it is known that the Hedgehog pathway is the established pathway for activating Gli1. In experiments the researchers then went on to show that a combination of the mTOR inhibitor everolimus (Afinitor) and the Hedgehog inhibitor vismodegib (Erivedge) steeply reduced the tumor burden in a mouse model of esophageal adenocarcinoma.
Our tool would in seconds let you know how many and which drug are available for potential drug combination therapies in affecting both the Hedgehog- and the mTOR pathway. It also would instantly tell you which drugs is available affecting both pathways. You could then further refine the results by up to eleven drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.). There after you can view in-depth progress reports on each of the drugs of interest to you (Premium version).
The Oncology Drug Pathway Analyzer comes in two versions, Standard and Premium. The additional great feature of the Premium version is that it also gives you instant access to more than 3,500 up to date and extensive drug developmental profiles (for free).

Standard (6,900 EURO)Premium (9,900 EURO)
Investigate Single Pathways or Crosstalk between Pathways
Filter results via drug specific parameters
See the Number of and Names of competing Companies targeting selected Pathways
See the Number of, Name and Status of Drugs targeting selected Pathways
Link-out enabled contents for in-depth pathway information and corporate information
Charts and Graphs presenting pathway findings
Target and Developmental Project information for each drug
Print to PDF Report of pathway findings
Nearly 3000 in-depth drug profile reports through a dynamic report generator


BioSeeker delivers Oncology Drug Pathway Analyzer as a Desktop App (see system requirements). This software requires no installation:
- Operating system: Windows (2000/XP/Vista/7/8) for Mac Users the service is only available online
- Browser Application (Internet Explorer, Firefox, Chrome, Safari)
- Internet access (to access related internet resources)

Table Of Contents

Oncology Drug Pathway Analyzer (Standard Version)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Europe Cancer Diagnostic Testing Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology

2016 Europe Cancer Diagnostic Testing Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology

  • $ 34500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

World Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

World Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Blood Disease Statistics

  • December 2016
    8 pages
  • Therapy  

    Blood Disease  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Related Market Segments :

Cancer

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.